Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by CaneIsAbelon Oct 15, 2020 9:17am
210 Views
Post# 31720132

Believe it or not it’s not as bad as people think

Believe it or not it’s not as bad as people think

Irwin Simon definitely has not proven himself and has diluted and continues to plan dilution in the future.   I keep telling everyone over and over we need a CEO who can make deals and not be invested time, money and energy in other companies. 

With that being said, the cash on hand was short because Irwin Simons failed supply deal with Emblem was paid out. Which is insane because we never have more supply on hand then last quarter. What a terrible CEO so far anyway. 

He did mention the dilution is for future expansions and acquisitions so he may only draw on it to coincide with a buy. 

Recreational growth grew massively and we dominate the market. 

we are beginning our shipments utilizing our EU certification to CC pharma which will reflect next quarter. 

I don't think the cash from the Israel deal was reflected her that may be in the next quarter. 

we still have 400 million in cash and the 100 million at market was filled rather quickly. 

At this point it's just a line of credit we can draw on when others can't borrow a pencil sharpener. 

We only posted a 2 cent loss per share which to me wasn't bad at all. We still have the election possible mergers and partnerships. Recreational growth is growing exponentially. The Covid 19 pandemic is effecting our cash from Germany but that won't be permanent and we began major shipments just the other week. We're not in bad shape at all. 

<< Previous
Bullboard Posts
Next >>